19686

    544009

    BLUEJET

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BLUE JET HEALTHCARE LTD Share Price Today

    BLUE JET HEALTHCARE LTD is currently trading at ₹562.7, down by ₹16.45 from the previous close. The stock touched an intraday high of ₹585.30 and a low of ₹557.10 during the latest trading session. Over the past one year, BLUE JET HEALTHCARE LTD has delivered a loss of 35.54%, while the stock has gained 28.45% in the last one month.

    BLUE JET HEALTHCARE LTD performance

    Today’s low Today’s high
    ₹ 557.10 ₹ 585.30
    ₹ 562.70
    52 week low 52 week high
    ₹ 325.00 ₹ 1027.80
    ₹ 562.70
    Open Price ₹ 578.95
    Prev. Close ₹ 579.15
    Volume (Shares) 690443.00
    Total traded value ₹ 3885.12
    Upper Circuit ₹ 637.05
    Lower Circuit ₹ 521.25
    info

    Investment Returns

    Over 1 Month 28.45% Over 3 Months 61.97% Over 6 Months 9.92% Over 1 Year -35.54%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BLUE JET HEALTHCARE LTD fundamentals


    • Market cap (Cr) 9,760.90
    • P/E Ratio (TTM) 40.51
    • Beta 1.50
    • Book Value / share 78.39
    • Return on equity 30.85%
    • EPS (TTM) 14.29
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 64.34
    info icon alternate text
    • Market cap (Cr) 9,746.20
    • P/E Ratio (TTM) 40.51
    • Beta 1.41
    • Book Value / share 78.39
    • Return on equity 30.85%
    • EPS (TTM) 14.29
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 64.34
    info icon alternate text

    BLUE JET HEALTHCARE LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 234.67
    Operating Expense 170.44
    Net Profit 64.34
    Net Profit Margin (%) 27.41
    Earnings Per Share (EPS) 3.71
    EBITDA 94.19
    Effective Tax Rate (%) 26.17
    Particulars DEC 2025 (Values in Cr)
    Revenue 192.41
    Operating Expense 151.85
    Net Profit 40.17
    Net Profit Margin (%) 20.87
    Earnings Per Share (EPS) 2.32
    EBITDA 60.10
    Effective Tax Rate (%) 25.30
    Particulars SEP 2025 (Values in Cr)
    Revenue 165.48
    Operating Expense 121.03
    Net Profit 52.14
    Net Profit Margin (%) 31.50
    Earnings Per Share (EPS) 3.01
    EBITDA 79.23
    Effective Tax Rate (%) 24.13
    Particulars JUN 2025 (Values in Cr)
    Revenue 354.76
    Operating Expense 240.15
    Net Profit 91.17
    Net Profit Margin (%) 25.69
    Earnings Per Share (EPS) 5.26
    EBITDA 129.25
    Effective Tax Rate (%) 25.79
    Particulars MAR 2025 (Values in Cr)
    Revenue 340.45
    Operating Expense 205.45
    Net Profit 110.10
    Net Profit Margin (%) 32.33
    Earnings Per Share (EPS) 6.35
    EBITDA 152.19
    Effective Tax Rate (%) 25.21
    Particulars MAR 2026 (Values in Cr)
    Revenue 947.32
    Operating Expense 683.46
    Net Profit 247.82
    Net Profit Margin (%) 26.16
    Earnings Per Share (EPS) 14.29
    EBITDA 362.75
    Effective Tax Rate (%) 25.47
    Particulars MAR 2025 (Values in Cr)
    Revenue 1029.99
    Operating Expense 670.14
    Net Profit 305.20
    Net Profit Margin (%) 29.63
    Earnings Per Share (EPS) 17.59
    EBITDA 423.99
    Effective Tax Rate (%) 24.84
    Particulars MAR 2024 (Values in Cr)
    Revenue 711.60
    Operating Expense 510.62
    Net Profit 163.75
    Net Profit Margin (%) 23.01
    Earnings Per Share (EPS) 9.44
    EBITDA 248.35
    Effective Tax Rate (%) 25.59
    Particulars MAR 2023 (Values in Cr)
    Revenue 720.98
    Operating Expense 528.33
    Net Profit 160.03
    Net Profit Margin (%) 22.19
    Earnings Per Share (EPS) 9.23
    EBITDA 243.04
    Effective Tax Rate (%) 26.12
    Particulars MAR 2022 (Values in Cr)
    Revenue 683.47
    Operating Expense 459.65
    Net Profit 181.59
    Net Profit Margin (%) 26.56
    Earnings Per Share (EPS) 10.47
    EBITDA 268.68
    Effective Tax Rate (%) 25.34
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3332.27
    ROE % 50.18
    ROCE % 55.94
    Total Debt to Total Equity 0.24
    EBITDA Margin 42.02
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 30430.17
    ROE % 71.97
    ROCE % 71.21
    Total Debt to Total Equity 0.39
    EBITDA Margin 40.79
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 65.32
    ROE % 30.85
    ROCE % 40.38
    Total Debt to Total Equity 0.01
    EBITDA Margin 41.16
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 48.73
    ROE % 21.45
    ROCE % 28.55
    Total Debt to Total Equity 0.01
    EBITDA Margin 34.90
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 39.29
    ROE % 26.60
    ROCE % 35.31
    Total Debt to Total Equity 0.02
    EBITDA Margin 33.71
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 30.07
    ROE % 42.16
    ROCE % 52.52
    Total Debt to Total Equity 0.08
    EBITDA Margin 39.31
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3428.35
    ROE % 52.64
    ROCE % 58.49
    Total Debt to Total Equity 0.23
    EBITDA Margin 43.18
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 70.45
    Total Assets 536.27
    Total Liabilities 536.27
    Total Equity 339.81
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 25.81
    Return on Capital (%) 35.37
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 15.22
    Total Assets 375.39
    Total Liabilities 375.39
    Total Equity 202.74
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 38.58
    Return on Capital (%) 51.67
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 119.78
    Total Assets 1417.53
    Total Liabilities 1417.53
    Total Equity 1133.11
    Share Outstanding 17
    Price to Book Ratio 13.48
    Return on Assets (%) 21.53
    Return on Capital (%) 26.93
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 84.70
    Total Assets 1058.84
    Total Liabilities 1058.84
    Total Equity 845.22
    Share Outstanding 17
    Price to Book Ratio 7.85
    Return on Assets (%) 15.46
    Return on Capital (%) 19.37
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 65.63
    Total Assets 862.06
    Total Liabilities 862.06
    Total Equity 681.48
    Share Outstanding 17
    Price to Book Ratio 0.00
    Return on Assets (%) 18.56
    Return on Capital (%) 23.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 87.66
    Total Assets 713.37
    Total Liabilities 713.37
    Total Equity 521.54
    Share Outstanding 17
    Price to Book Ratio 0.00
    Return on Assets (%) 25.45
    Return on Capital (%) 34.82
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 70.45
    Total Assets 533.56
    Total Liabilities 533.56
    Total Equity 339.81
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 26.54
    Return on Capital (%) 37.7
    Particulars MAR 2021 (Values in Cr)
    Net Income 184.65
    Cash from Operations 129.47
    Cash from Investing -50.72
    Cash from Financing -27.49
    Net change in Cash 51.05
    Free Cash Flow 161.58
    Particulars MAR 2020 (Values in Cr)
    Net Income 194.12
    Cash from Operations 171.35
    Cash from Investing -45.23
    Cash from Financing -72.49
    Net change in Cash 4.99
    Free Cash Flow 187.37
    Particulars MAR 2025 (Values in Cr)
    Net Income 406.09
    Cash from Operations 134.80
    Cash from Investing -35.18
    Cash from Financing -18.55
    Net change in Cash -7.97
    Free Cash Flow 214.68
    Particulars MAR 2024 (Values in Cr)
    Net Income 220.09
    Cash from Operations 252.34
    Cash from Investing -263.75
    Cash from Financing -1.98
    Net change in Cash -24.48
    Free Cash Flow 425.20
    Particulars MAR 2023 (Values in Cr)
    Net Income 216.61
    Cash from Operations 201.53
    Cash from Investing -147.25
    Cash from Financing -4.23
    Net change in Cash -9.93
    Free Cash Flow 260.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 243.23
    Cash from Operations 174.00
    Cash from Investing -76.02
    Cash from Financing -56.14
    Net change in Cash 14.24
    Free Cash Flow 195.79
    Particulars MAR 2021 (Values in Cr)
    Net Income 190.48
    Cash from Operations 136.98
    Cash from Investing -60.98
    Cash from Financing -20.54
    Net change in Cash 55.25
    Free Cash Flow 171.94
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2402.90 42.30 17.95 40706.58 2088.00 3356.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8200.05 107.09 23.48 20500.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90

    BLUE JET HEALTHCARE LTD shareholding pattern

    Holding
    15.13%
    79.81%
    0.39%
    4.65%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    BLUE JET HEALTHCARE LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    562.70 -2.84 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 560.90
    • 26 Days 515.20
    • 10 Days 546.30
    • 50 Days 487.90
    • 12 Days 541.40
    • 100 Days 476.80
    • 20 Days 525.00
    • 200 Days 509.40
    573.82 PIVOT
    First Support 561.33 First Resistance 591.63 Second Support 543.52 Second Resistance 604.12 Third Support 531.03 Third Resistance 621.93
    RSI 71.72 ADX 48.13 MACD 26.20 Williams % R -8.65 Commodity Channel Index (CCI) 170.66
    Date 2026-07-07 Week 381570.00 Same Day 723820.00 Month 301754.00
    1 Year 1.51 3 Year 1.25
    Over 1 Month
    28.45% down
    Over 1 Year
    -35.54% down
    Over 3 Months
    61.97% down
    Over 3 Years
    11.89% down
    Over 6 Months
    9.92% down
    Over 5 Years
    0.00% down

    BLUE JET HEALTHCARE LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 1.2 Final 19 Sep 2025 Equity shares
    17 Sep 2024 1.0 Final 18 Sep 2024 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 1.2 Final 19 Sep 2025 Equity shares
    17 Sep 2024 1.0 Final 18 Sep 2024 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Blue Jet Healthcare Ltd?

    Answer Field

    Blue Jet Healthcare Ltd share price is for NSE ₹ 562.70 & for BSE ₹ 565.00 as on Jul 08 2026 03:30 PM.

    What is the Market Cap of Blue Jet Healthcare Ltd Share?

    Answer Field

    The market cap of Blue Jet Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 08 2026 03:30 PM.

    What is the 52 Week High and Low of Blue Jet Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Blue Jet Healthcare Ltd for NSE is ₹ 1,027.80 and ₹ 325.00 and for BSE is ₹ 1,028.20 and ₹ 325.20.

    What is 1 year return for Blue Jet Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been -35.54%.

    What is the P/E Ratio of Blue Jet Healthcare Ltd Share?

    Answer Field

    As on Jul 08 2026 03:30 PM the price-to-earnings (PE) ratio for Blue Jet Healthcare Ltd share is 40.51.

    What is the PB ratio of Blue Jet Healthcare Ltd Share?

    Answer Field

    As on Jul 08 2026 03:30 PM, the price-to-book (PB) ratio for Blue Jet Healthcare Ltd share is 78.39.

    How to Buy Blue Jet Healthcare Ltd Share?

    Answer Field

    You can trade in Blue Jet Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Blue Jet Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Blue Jet Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Blue Jet Healthcare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |